Pivekimab sunirine Antibody
Pivekimab sunirine (IMGN 632) is a CD123-targeting antibody-drug conjugate (ADC) for research use, comprising an anti-CD123 antibody linked to an indolinobenzodiazepine pseudodimer payload. It is utilized in preclinical studies, including in vitro and in vivo models, to investigate potential therapies for hematological malignancies such as acute myeloid leukemia.
Product Specifications
Target
Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog